Clinical Trial Update: Pharmacokinetic Study of IV Artesunate to Treat Children With Severe Malaria [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetic study evaluating intravenous artesunate in children with severe malaria has completed; the trial was sponsored by NIAID and assessed PK …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Artesunate (artesunate)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Plasmodium Falciparum Infection | Phase 4 | Status: COMPLETED